Literature DB >> 8027065

Comparable 30-kDa apamin binding polypeptides may fulfill equivalent roles within putative subtypes of small conductance Ca(2+)-activated K+ channels.

J D Wadsworth1, K B Doorty, P N Strong.   

Abstract

Apamin, a peptide neurotoxin from bee venom, blocks small conductance Ca(2+)-activated K+ channels in central synapses and peripheral tissues. Using 125I-apamin, single classes of high affinity binding sites (Kd 1-3 pM) were identified on plasma membranes from rat, rabbit, guinea pig, and bovine brain and from rabbit, guinea pig, and bovine liver. Binding was sensitive to scyllatoxin, dequalinium, gallamine, and d-tubocurarine but not to charybdotoxin, toxin I, or mast cell degranulating peptide. In contrast, saturable binding of 125I-apamin to rat liver plasma membranes was virtually undetectable, thereby providing a correlation with the ability to measure apamin-sensitive Ca(2+)-activated potassium currents in rabbit and guinea pig hepatocytes but not in rat hepatocytes. In agreement with membrane binding studies, homobifunctional cross-linkers identified apparently identical 33-kDa 125I-apamin binding polypeptides on brain plasma membranes from all species and analogous but distinct polypeptides on plasma membranes from rabbit, guinea pig, and bovine liver. None of these affinity-labeled polypeptides were detectable on plasma membranes from rat liver. Affinity labeling was abolished on both liver and brain membranes by apamin, scyllatoxin, dequalinium, gallamine, and d-tubocurarine. These results indicate that comparable approximately 30-kDa polypeptides may fulfill equivalent functional roles within putative subtypes of apamin-sensitive small conductance Ca(2+)-activated K+ channels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027065

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Effects of inhibitors of small- and intermediate-conductance calcium-activated potassium channels, inwardly-rectifying potassium channels and Na(+)/K(+) ATPase on EDHF relaxations in the rat hepatic artery.

Authors:  D A Andersson; P M Zygmunt; P Movahed; T L Andersson; E D Högestätt
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  The pharmacology of hSK1 Ca2+-activated K+ channels expressed in mammalian cell lines.

Authors:  M Shah; D G Haylett
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  Compounds that block both intermediate-conductance (IK(Ca)) and small-conductance (SK(Ca)) calcium-activated potassium channels.

Authors:  M Malik-Hall; C R Ganellin; D Galanakis; D H Jenkinson
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  Ca(2+)-activated K+ channels of human and rabbit erythrocytes display distinctive patterns of inhibition by venom peptide toxins.

Authors:  C Brugnara; C C Armsby; L De Franceschi; M Crest; M F Euclaire; S L Alper
Journal:  J Membr Biol       Date:  1995-09       Impact factor: 1.843

5.  Apamin-sensitive K+ channels mediate an endothelium-dependent hyperpolarization in rabbit mesenteric arteries.

Authors:  M E Murphy; J E Brayden
Journal:  J Physiol       Date:  1995-12-15       Impact factor: 5.182

6.  SK3 is an important component of K(+) channels mediating the afterhyperpolarization in cultured rat SCG neurones.

Authors:  R Hosseini; D C Benton; P M Dunn; D H Jenkinson; G W Moss
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

Review 7.  The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword.

Authors:  Jun Chen; William R Lariviere
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

8.  Discrimination between subtypes of apamin-sensitive Ca(2+)-activated K+ channels by gallamine and a novel bis-quaternary quinolinium cyclophane, UCL 1530.

Authors:  P M Dunn; D C Benton; J Campos Rosa; C R Ganellin; D H Jenkinson
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  The relationship between functional inhibition and binding for K(Ca)2 channel blockers.

Authors:  David Charles Hammond Benton; Monique Garbarg; Guy William John Moss
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.